Is the Harvey Norman (ASX:HVN) share price dirt cheap?

Is it time to buy this retail giant's shares?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Harvey Norman Holdings Limited (ASX: HVN) share price has been out of form in recent months.

Since peaking at a 52-week high of $6.09 in August, the retail giant's shares have fallen 17% to $5.05.

A young woman in a retail shop holding her wallet open ready to pay for her items using Afterpay

Image source: Getty Images

Is the Harvey Norman share price weakness a buying opportunity?

One leading broker that sees the weakness in the Harvey Norman share price as a buying opportunity is Goldman Sachs.

According to a note this morning, the broker has retained its buy rating and $6.00 price target on the company's shares. Based on the current Harvey Norman share price, this implies potential upside of almost 19% over the next 12 months.

In addition, the broker is forecasting a 36 cents per share fully franked dividend in FY 2022. This implies a very generous 7.1% yield, bringing the total potential return on offer to 26%.

What did the broker say?

Goldman notes that Harvey Norman has recently released a trading update which revealed positive growth year to date in all regions outside of Malaysia versus the comparable period in 2019.

Overall, the trading update was largely in line with the broker's expectations, with sales trends in Australia and Europe remaining slightly ahead of expectations and Asia remaining weaker.

Pleasingly, the broker expects this positive form to continue due to favourable trading conditions.

Its analysts commented: "We update our earnings outlook on HVN to reflect the latest trading update. We continue to expect the underlying sales growth vs. pre-COVID levels to remain strong due to the positive housing related spending environment and an overall expected increase in spending for the home category. Additionally, we also update our FX forecasts for HVN, in line with the latest GSe. Overall, this results in a revision of group EBIT outlook by +0.1% and +0.8% respectively over FY22 and FY23e respectively. Our 12m Target Price for HVN remains unchanged at A$6.00 and we maintain a Buy rating on HVN."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Harvey Norman Holdings Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Man sitting in a plane seat works on his laptop.
Broker Notes

Down 34% in 2026, are Virgin Australia shares a good buy today?

A leading analyst delivers his outlook for Virgin Australia’s beaten-down shares.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Why these ASX shares are rated as buys in April

Let's see what makes them bullish on these names right now.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »